Recruitment And Diversity

  1. PI Talks Recruitment, Retention, & Trial Design For Multiple Myeloma Studies 10/28/2024

    Multiple myeloma specialist James Berenson, MD discusses trial selection, recruitment strategies, patient-centric trial design, and more.

  2. Overcoming Trial Barriers By Looking Through The Lens Of Product Adoption 10/17/2024

    In the final article of this series, Liam and Kim Eves explore how various drug candidates come inherent with barriers to adoption that directly impact how participants and providers engage with clinical research. 

  3. Understanding How Strategies For Product Adoption Can Inform Clinical Trial Delivery 10/16/2024

    In part two of this series, Liam and Kim Eves discuss product archetypes and adoption drivers as they relate to commercial endeavors and looks closely at how they can be applied to clinical trial execution.

  4. What Can Clinical Researchers Learn From Commercial Product Launches? 10/15/2024

    Part one of this three-part series exploring modern drug development and its impact on clinical trials and new drug launches connects product adoption concepts with much earlier clinical trial activities.

  5. What's A Better Tactic For Patient Recruitment — "Unreasonable Hospitality" Or The Same Old? 10/10/2024

    When it comes to patient recruitment, which is a better strategy: sticking to the same old routine or becoming unreasonably hospitable? Consultant Ross Jackson explores both options.

  6. Site Visits 101: Visits Before, Without, And After Trial Participants 10/3/2024

    Discover the primary visit types that occur at a clinical research site before, without, and after the presence of clinical trial participants.

  7. Site Visits 101: Visits With Participants, From Prescreening To Completion 10/3/2024

    Discover all of the clinical research site visits that include patients, from the time they are prescreened to — if enrolled — the time they complete the study.

  8. Continuing Rare Disease Treatment With A Compassionate Use Program (CUP) 10/2/2024

    Learn how Rezolute successfully led its investigational drug for treating congenital hyperinsulinism (cHI) through a compassionate use program.

  9. Compassionate Use Program (CUP) Benefits & Strategies In Rare Disease 10/2/2024

    In part two of this series, Rezolute discusses the benefits of continuing patient care with a compassionate use program (CUP) and shares best practices for implementing one.

  10. Why Diversity Of Geography Matters: A Call To Drive Rural Patient Enrollment 9/30/2024

    To make clinical trials more inclusive, CROs and sponsors must intentionally expand to different — including rural — communities to recruit more diverse patients.